• 09.02.2017 // Specials
    Integrating qualified refugees into the local labor market of western societies strengthens our communities, reduces public spending and allows people to lead independent lives again.QIAGEN actively supports these efforts in the Mettmann Region.
    more
  • 03.02.2017 // Feature
    For years, RNA research lagged behind investigations of DNA. Now, a growing understanding of RNA’s vital role in regulating normal physiology is attracting increasing interest - revealing a powerful driver of both disease and health.

    more
  • 10.11.2016 // Feature
    The microbiome remains a largely undocumented realm. The MetaSUB consortium brings together researchers from around the globe to explore the interactions between microbes and their environments.
    more
  • 10.10.2016 // Interview
    We met Prof. Soonmyung Paik, one of today’s leading pathologists in breast cancer research, to learn more about his perspective on the vibrant research landscape in Korea and Asia.
    more
  • 11.09.2016 // Interview
    We asked three well-known leaders in the genomic revolution to discuss the future of molecular testing and medicine.
    more
  • 29.07.2016 // Feature
    Tiziana Lazzarotto cares for people who have organ transplants - serving not at their hospital beds, but in the virology laboratory of one of Europe's most renowned transplant clinics. Valuable insights from QIAGEN tests help guide decisions critical to the patients' lives.
    more
  • 08.07.2016 // News
    QIAGEN has a proven track record of providing advanced Sample to Insight solutions to help tackle global health emergencies, such as the Zika virus. This outbreak is already overshadowing the Summer Olympics in Brazil.
    more
  • 14.06.2016 // Feature
    The largest-ever DNA identification project is underway to name those who perished more than 40 years ago in the Vietnam War. An international consortium involving QIAGEN is supporting the Vietnamese scientists to overcome the considerable challenges of the vast project.
    more
  • 11.05.2016 // Feature
    The approach to conquering cancer has shifted from using chemotherapy to deploying precision-guided drugs targeted to each patient’s unique genomic characteristics. In the future, advanced gene panels and next-generation sequencing promise to deliver more victories to oncologists and their patients.
    more
Back to top